JW (CAYMAN) THERAPEUTICS CO. LTD
(HKEX: 2126)
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquartered in Shanghai, China.
2.310 -
-0.060
(-2.53%)
价格区间
2.310 - 2.370
(2.60%)
开盘
2.370
昨收
2.370
买
2.310
买盘
('000)
121.5
卖
2.360
卖盘
('000)
20
成交量
('000)
738
成交额
1,714,455
注释
-
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动
Loading Chart...
Please login to view stock data and analysis
